{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PRKN",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "209"
        },
        "variant_string_id": "PRKN G209D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkin mutations disrupt its role as a p53 repressor, leading to increased apoptosis of dopaminergic neurons.",
          "judgment": "Yes",
          "reasoning": "The paper clearly links parkin dysfunction to enhanced p53 activity and neuronal loss."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "ChIP experiments and transactivation assays were employed.",
          "judgment": "Yes",
          "reasoning": "These assays are relevant for studying transcriptional regulation and validate the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type parkin was likely used as a control, but details on replicates and variant controls were not provided.",
          "judgment": "Yes",
          "reasoning": "While basic controls may be present, the lack of explicit replicate information and variant controls limits the strength."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Mutations enhance p53 expression, indicating loss of parkin function.",
          "judgment": "Yes",
          "reasoning": "The functional data supports pathogenicity but lacks statistical details for OddsPath calculation."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The variant disrupts parkin's ability to repress p53, supporting its pathogenic role in AR-JP without high statistical confidence."
    }
  ]
}